Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome
- 1 January 1997
- journal article
- Published by Elsevier in The Lancet
- Vol. 349 (9047) , 225-230
- https://doi.org/10.1016/s0140-6736(96)09095-2
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- The use of intravenous immunoglobulins in the treatment of neuromuscular disordersCurrent Opinion in Neurology, 1996
- Campylobacter jejuniInfection and Guillain–Barré SyndromeNew England Journal of Medicine, 1995
- Immunopathogenesis and treatment of the guillain–barré syndrome—part IIMuscle & Nerve, 1995
- Immunopathogenesis and treatment of the guillain‐barré syndrome—part IMuscle & Nerve, 1995
- Guillain‐Barré syndrome with severe persistent disability: relationship to hyperacute Guillain‐Barré syndromeEuropean Journal of Neurology, 1994
- Kinetics of Anti-Peripheral Nerve Myelin Antibody in Patients With Guillain-Barre Syndrome Treated and Not Treated With PlasmapheresisArchives of Neurology, 1991
- A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value.Journal of Neurology, Neurosurgery & Psychiatry, 1988
- Motor conduction studies in guillain‐barré syndrome: Description and prognostic valueAnnals of Neurology, 1988
- Plasmapheresis and guillain‐barré syndrome: Analysis of prognostic factors and the effect of plasmapheresisAnnals of Neurology, 1988
- Efficiency of plasma exchange in Guillain‐Barré syndrome: Role of replacement fluidsAnnals of Neurology, 1987